Have any questions? 706-721-6582 or cts@augusta.edu
This is a research study to test a new drug called Navitoclax that is not approved by the Food and Drug Administration (FDA) to treat Myelofibrosis. We are looking to see if the drug works on your cancer, if the drug is safe and what type of treatment is better. This study has two different groups you can be assiged to: navitoclax + ruxolitinib or ruolitinib + placebo. This assignment is done at random, as with the flip of a coin.